Background:

Currently, China’s medical device industry has entered a critical phase of “high-end, independent, and internationalized” development. The domestic medical device market is projected to reach RMB 1.35 trillion by 2026, solidifying its position as the world’s second-largest market. Concurrently, the overseas expansion of domestic medical devices continues to gather pace, with total exports expected to surpass USD 40 billion in the first three quarters of 2026, maintaining steady year-on-year growth and unlocking sustained potential for industrial development. However, the “bottleneck” issue concerning core electronic components remains pronounced. Key hardware, such as components for high-end imaging equipment and high-precision sensors, still heavily rely on imports. This not only hampers the localization process of high-end medical devices but also poses risks to supply chain security, which are incompatible with the high-quality development demands of China’s healthcare industry.

At the policy level, the government is intensifying its support efforts. The “15th Five-Year Plan” for the medical equipment industry’s development has now entered its implementation stage, clearly articulating the core objective of “focusing on breakthroughs in core components and key parts of high-end medical equipment, comprehensively enhancing self-sufficiency, and fostering deep collaboration among industry, academia, research, and healthcare.” The Ministry of Industry and Information Technology (MIIT) has further refined its innovation support initiatives for core components, emphasizing technological advancements and guiding the translation of research outcomes, in alignment with the 2026 industry development priorities. The National Healthcare Security Administration (NHSA) has listed “supporting the overseas expansion of pharmaceuticals and medical devices and promoting the localization of core components” as a key task for 2026, while also enhancing supportive policies. At the regional level, provinces such as Shanghai, Jiangsu, and Guangdong have unveiled corresponding measures for 2026 aimed at accelerating the establishment of innovation platforms, fostering industry-academia-research cooperation, and advancing the localization of core components.

Against this backdrop, the momentum for localizing core electronic components in China’s medical device industry continues to build. Enterprises and academic research institutions are deepening their partnerships, gradually breaking foreign monopolies, and driving the shift of domestic substitution from “laboratory research” to “industrialization.” However, the industry still grapples with practical challenges such as insufficient breakthroughs in core technologies, poor industry-academia-research collaboration, low mass production yield rates, and inadequate clinical adaptability. These issues indicate a notable disparity from the self-sufficiency goals set forth in the “15th Five-Year Plan.”

To create an effective communication platform for universities, enterprises, research institutions, policy-making bodies, and medical institutions, this technical forum is organized with a focus on achieving breakthroughs and industrial implementation in key product categories, tackling core challenges in the localization process, and fostering technological innovation and supply chain autonomy for core electronic components in medical devices. The forum aims to build industry consensus, share research achievements, deepen industry-academia-research collaboration, and support the high-quality development of China’s medical device industry.

Participants:

• High-end medical device companies: R&D, design, and process departments, as well as project/company leaders
• Core component manufacturers
• Other supporting supply chain enterprises and service providers

Clinicians, universities and research institutes